August 6, 2012
American Medical News
This article discusses Assn. for Molecular Pathology v. U.S. Patent and Trademark Office et al., and looks to legal experts on their thoughts regarding what the "appeals judges appeared to show their hand during re-arguments." Finnegan senior counsel, David S. Forman, Ph.D., provided commentary. Dr. Forman stated he would be “very surprised if the federal circuit rules substantially different from the first decision.” He also said, “It is probable that it’ll go back to the Supreme Court because it’s so controversial. Because of Prometheus, there is more uncertainty as to what the Supreme Court might do with this.”
Commentary
May 20, 2026
Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Press Release
Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination
May 11, 2026
Award/Ranking
Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey
May 7, 2026
Announcement
Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International
May 4, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.